Basic Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Dec 15, 2003; 9(12): 2772-2775
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2772
Table 1 Compositions of amino acid solution (g·L-1)
Amino acidsGroup AGroup BGroup CGroup D
Isoleucine5.55.55.55.5
Leucine7.57.57.57.5
Lysine7.07.07.07.0
Methionine6.06.0
Phenylalanine4.04.04.04.0
Threonine5.05.05.05.0
Tryptophan1.51.51.51.5
Valine6.06.0
Arginine6.06.06.06.0
Histidine3.03.03.03.0
Proline4.04.04.04.0
Tyrosine1.01.01.01.0
Alanine20.020.020.020.0
Glycine7.57.57.57.5
Aspartic acid4.04.04.04.0
Total amino acid88.082.082.076.0
Total nitrogen14.113.113.112.2
Table 2 Distribution of cancer cell cycle after EN treatment (%)
PhaseGroup AGroup BGroup CGroup D
G0G167.0 ± 5.178.9 ± 8.5ac69.2 ± 6.2b80.5 ± 9.0ac
S20.1 ± 1.811.8 ± 2.9ac19.9 ± 3.0b10.2 ± 2.1ac
G2+M12.9 ± 3.29.2 ± 3.110.9 ± 2.59.4 ± 3.8
PI(S+G2+M)33.0 ± 4.321.0 ± 5.0ac30.8 ± 5.6b20. 5 ± 2.8ac
Table 3 Changes in tumor volumes, IRT and MST before and after treatment
GroupTumor volumes
IRT(%)MST(d)
BeforeAfter
Group A0.028 ± 0.0152.85 ± 0.43...26.8 ± 1.5
Group B0.039 ± 0.0101.79 ± 0.56a37.232.0 ± 2.6a
Group C0.033 ± 0.0201.90 ± 0.30ab33.335.6 ± 3.2a
Group D0.031 ± 0.0111.60 ± 0.40abc43.939.4 ± 3.0abc